Immuno Oncology • Autologous Cell Therapy • Tumor Infiltrating Lymphocytes (TIL) • Novel Cancer Immunotherapies • cell therapy
3 days ago
Immuno Oncology • Autologous Cell Therapy • Tumor Infiltrating Lymphocytes (TIL) • Novel Cancer Immunotherapies • cell therapy
• Develop and execute the HEOR strategy, ensuring alignment with market access, regulatory, and clinical objectives. • Design, develop, and manage health economic models, including cost-effectiveness analyses and budget impact models. • Collaborate with internal stakeholders to identify evidence that will support product value and conduct real-world evidence studies to demonstrate the clinical and economic value of oncology therapies. • Manage quality-of-life (QoL) data for all clinical trials. • Oversee the preparation of HEOR-related documents, including dossiers, payer presentations, and publication of research findings. • Lead and participate in interactions with external stakeholders such as health economics, payers, and key opinion leaders. • Stay abreast of industry trends, policies, and regulatory requirements related to HEOR. • Communicate HEOR updates, recommendations, and analysis regularly to the broader Iovance organization, including to senior leadership. • Must adhere to Iovance Biotherapeutics’ core values, policies, procedures, and business ethics.
• 12+ years of related experience in biopharmaceutical industry with extensive experience in health economics and outcomes research • Advanced degree in health economics, epidemiology, biological sciences, or related. • 5+ years of prior leadership experience, with proven people management skills. • Strong interpersonal, collaborative, and relationship-building skills. • Demonstrated strategic thinking skills, strong business acumen, and excellent process and management skills. • Superior strategic and tactical planning within a pharmaceutical environment is necessary. • Experience in submitting Health Technology Assessments in the EU. • Experience developing and aligning global pricing bands with senior management. • Cell therapy experience preferred, or otherwise oncology / rare disease experience. • Extensive knowledge of publicly available scientific literature, modeling assumptions, and reviews/appraisals of recent dossiers for high-cost drugs in major markets. • Experience modeling synthetic comparator arms to support ex-US dossiers based on single-arm trials. • Track record of successfully managing high-performing teams and delivering excellence. • Proven experience in developing and executing economic models and real-world evidence studies. • Deep technical understanding of HEOR modeling methodologies. • Extensive experience with developing dossiers to support health technology assessment submissions in multiple markets. • Excellent written and oral communication skills. • Proficient in presenting, with significant expertise in delivering presentations at the executive level.
Apply Now3 days ago
Manage the Promotions & Trade Spend team, fostering relationships with CPG brands at Green Spoon Sales.
4 days ago
As Associate Director, you'll guide omni-channel media strategies and insights. You'll collaborate with top brands to drive measurable results and enhance agency capabilities.
5 days ago
Join Telix Pharmaceuticals as a Senior Director, leading nuclear medicine for oncology products. Focus on dosimetry, imaging expertise, and clinical trials.
5 days ago
As Associate Director, lead Total Rewards initiatives for Gemini, a crypto and Web3 platform. Focus on benefits, wellness, and compensation strategies to attract and retain talent.
5 days ago
Serve as Program Manager and lead oncology clinical research projects at Tempus. Collaborate with clients and team members for effective outcomes.